A team has identified an experimental molecule capable of "reprogramming" the brain's immune cells to restore part of their ...

The South San Francisco biotech plans to begin its first human trial of a liver cell-reprogramming therapy next year ...

Gear-obsessed editors choose every product we review. We may earn commission if you buy from a link. Why Trust Us? Here’s what you’ll learn when you read this story: A scientist wants to reprogram ...

A new study reveals that reprogramming specialized cells to become different types of cells, a key process in regenerative medicine, faces a major hurdle. The challenge lies in the DNA methylation ...

A mature cell of one type can be turned into a mature cell of another type without the cell having to pass through an earlier stage of development. This is called direct reprogramming, a reliable but ...

The interdisciplinary Center for Information Integrity provides support for collaborative research, public discussions and community outreach on mis/disinformation awareness and resilience.

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in pancreatic cancer—and identified a promising strategy to overcome that resistance.

The Spanish scientist works at Altos Labs, a secretive US biotech company funded by billionaires seeking to eliminate the ...

AI is transforming longevity as companies like METiS TechBio and Human Longevity use algorithms to combat ageing and predict health risks For Beijing-based METiS TechBio CEO Lai Tsai-ta, ageing is ...

Mesenchymal drift may help explain how cells lose stable identity and acquire pro-fibrotic, inflammatory mesenchymal traits ...